X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA UNICHEM LAB PLETHICO PHARMA/
UNICHEM LAB
 
P/E (TTM) x -1.1 -276.0 - View Chart
P/BV x 0.0 2.0 0.8% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 PLETHICO PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
UNICHEM LAB
Mar-17
PLETHICO PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs395320 123.4%   
Low Rs31221 14.2%   
Sales per share (Unadj.) Rs604.4167.2 361.5%  
Earnings per share (Unadj.) Rs32.512.0 271.6%  
Cash flow per share (Unadj.) Rs51.316.9 303.2%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs473.6117.0 404.6%  
Shares outstanding (eoy) m34.0890.88 37.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.41.6 21.8%   
Avg P/E ratio x6.622.6 29.0%  
P/CF ratio (eoy) x4.216.0 26.0%  
Price / Book Value ratio x0.52.3 19.5%  
Dividend payout %025.1 0.0%   
Avg Mkt Cap Rs m7,26224,578 29.5%   
No. of employees `000NA5.2 0.0%   
Total wages/salary Rs m1,5962,487 64.2%   
Avg. sales/employee Rs ThNM2,928.3-  
Avg. wages/employee Rs ThNM479.4-  
Avg. net profit/employee Rs ThNM209.4-  
INCOME DATA
Net Sales Rs m20,59815,195 135.6%  
Other income Rs m386110 350.6%   
Total revenues Rs m20,98415,305 137.1%   
Gross profit Rs m2,8181,788 157.6%  
Depreciation Rs m642452 142.2%   
Interest Rs m1,59334 4,727.6%   
Profit before tax Rs m9691,413 68.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138326 -42.5%   
Profit after tax Rs m1,1071,087 101.8%  
Gross profit margin %13.711.8 116.3%  
Effective tax rate %-14.323.1 -62.0%   
Net profit margin %5.47.2 75.1%  
BALANCE SHEET DATA
Current assets Rs m18,8776,426 293.8%   
Current liabilities Rs m11,8963,917 303.7%   
Net working cap to sales %33.916.5 205.3%  
Current ratio x1.61.6 96.7%  
Inventory Days Days3668 53.1%  
Debtors Days Days19877 257.0%  
Net fixed assets Rs m9,8617,410 133.1%   
Share capital Rs m341182 187.4%   
"Free" reserves Rs m12,33110,454 117.9%   
Net worth Rs m16,13910,636 151.7%   
Long term debt Rs m4,7064 106,950.0%   
Total assets Rs m33,14615,258 217.2%  
Interest coverage x1.642.9 3.7%   
Debt to equity ratio x0.30 70,485.8%  
Sales to assets ratio x0.61.0 62.4%   
Return on assets %8.17.3 110.9%  
Return on equity %6.910.2 67.1%  
Return on capital %12.313.6 90.4%  
Exports to sales %21.424.1 88.6%   
Imports to sales %15.24.9 307.8%   
Exports (fob) Rs m4,4023,666 120.1%   
Imports (cif) Rs m3,136752 417.2%   
Fx inflow Rs m4,4025,298 83.1%   
Fx outflow Rs m3,1840-   
Net fx Rs m1,2195,298 23.0%   
CASH FLOW
From Operations Rs m2,437683 356.7%  
From Investments Rs m-6,265-1,316 476.2%  
From Financial Activity Rs m2,490592 420.5%  
Net Cashflow Rs m-1,337-40 3,351.3%  

Share Holding

Indian Promoters % 82.7 50.1 165.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 15.1 28.5%  
FIIs % 5.5 3.0 183.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 31.7 23.7%  
Shareholders   10,665 20,176 52.9%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   SUVEN LIFE  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  SHASUN PHARMA  

Compare PLETHICO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Idea Cellular Plunges 6%(12:30 pm)

After opening the day flat share markets in India are trading on a dull note and are presently trading marginally below the dotted line.

Related Views on News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 8-QTR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS